Company Filing History:
1 out of 2,405 
1 out of 47 
Years Active: 2013
Title: Thomas F N Haxell: Innovator in Cancer Treatment
Introduction
Thomas F N Haxell is a notable inventor based in Morrisville, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on inhibitors of Akt activity, which play a crucial role in cancer progression.
Latest Patents
Haxell holds a patent for "Inhibitors of Akt activity." This invention provides substituted fused naphthyridine derivatives that inhibit Akt activity. The compounds disclosed in this patent selectively inhibit one or two of the Akt isoforms. Additionally, the invention includes compositions comprising such inhibitory compounds and methods for administering the compound to patients in need of cancer treatment.
Career Highlights
Throughout his career, Haxell has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and MSD K.K. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Haxell has collaborated with notable professionals in his field, including Weiming Fan and Matthew G Jenks. These collaborations have further enhanced his research and development efforts in cancer treatment.
Conclusion
Thomas F N Haxell is a distinguished inventor whose work in developing Akt inhibitors has the potential to significantly impact cancer treatment. His contributions to the pharmaceutical industry demonstrate the importance of innovation in addressing critical health challenges.